Immundnz to organise a symposium on in vitro and in silico models in immuno-oncology.

Immundnz to organise a symposium on in vitro and in silico models in immuno-oncology.

Published on 13/01/2023

NOVEL INSIGHTS IN IMMUNO-ONCOLOGY: IN VITRO AND IN SILICO MODELS AND NEW TARGETS

Symposium organised by Immundnz Ltd

Alderley Park Conference Centre, Helix 2

Alderley Park, Cheshire, SK10 4TG

21 Feb 2023, 10 am – 4 pm

 

Immuno-oncology is still one of the hot topics in cancer research. The development of cancer immunotherapies requires appropriate and innovative preclinical models and technologies. New cellular models such as CAR-T, phagocytes, cytotoxic cells and dendritic cells are immunomodulatory targets in cutting edge cancer research as well as cell signalling checkpoints. Immundnz will organise a free-to-attend 1-day symposium at the Alderley Park that will cover innovative approaches to preclinical translational models and target areas in immuno-oncology. Speakers from several UK and Dutch research institutes and companies will present their latest insights. Full program can be found here.

 

Free to attend, including networking lunch.

 

For registration, you can sign up here or contact us at info@immundnz.com.

 

Our Valued Sponsors & Partners